Sign in

CIK 0001783328 · <br>Emerging growth company

TScan Therapeutics, Inc.

Sign in to watch
Ticker
TCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
825282075
Phone
857-399-9500
Business address
830 WINTER STREET, WALTHAM, MA, 02451
  1. 4 Insider Changes in Ownership
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. ARS Other Annual Report to Security Holders
  5. DEFA14A Proxy Proxy Materials
  6. DEF 14A Proxy Proxy Statement
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  10. EFFECT Other Notice of Effectiveness
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. UPLOAD Other SEC-generated Letter
  13. S-8 Other Securities Offered to Employees in Benefit Plans
  14. S-3 Offering Registration Statement
  15. 10-K Report Annual Report
  16. 8-K Event Results of operations
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  20. 4 Insider Changes in Ownership

Page 4 of 17 · 336 filings